Note Consolidated Group For the year ended 30 June 2024 $ For the year ended 30 June 2023 $ REVENUE AND COST OF SALES FROM ORDINARY ACTIVITIES Product revenue 3 535,118 398,193 Cost of sales (81,013) (44,482) GROSS PROFIT 454,105 353,711 OTHER INCOME Research and Development Tax Incentive refund 4 1,026,444 1,094,879 Grant income 4 – 58,130 Interest and miscellaneous income 4 256,581 353,721 TOTAL OTHER INCOME 1,283,025 1,506,730 OPERATING EXPENDITURES General and Administration 5 (5,158,586) (6,832,901) Research and Development 5 (2,699,591) (3,224,469) Sales and Marketing 5 (433,303) (772,312) TOTAL OPERATING EXPENDITURES (8,291,480) (10,829,682) LOSS BEFORE INCOME TAX (6,554,350) (8,969,241) Income tax credit/(expense) 6 – – LOSS AFTER INCOME TAX (6,554,350) (8,969,241) OTHER COMPREHENSIVE INCOME Items that may be subsequently reclassified to operating result Foreign currency translation 16 18,266 (206,345) OTHER COMPREHENSIVE GAIN/(LOSS) FOR THE YEAR, NET OF TAX 18,266 (206,345) TOTAL COMPREHENSIVE LOSS ATTRIBUTABLE TO THE MEMBERS OF INOVIQ LIMITED (6,536,084) (9,175,586) LOSS PER SHARE: Cents Cents Basic loss per share 18 (7.09) (9.75) Diluted loss per share 18 (7.09) (9.75) The accompanying notes form part of these financial statements. Consolidated Statement of Comprehensive Income for the year ended 30 June 2024 32 INOVIQ Limited
RkJQdWJsaXNoZXIy MjE2NDg3